For MYC + DLBCL patients, fewer patients were PET-negative at I-PET and EoT-PET (p < 0.001), and more patients were I-PET-negative and EoT-PET-positive (p = 0.002) compared to expected frequencies. Here, MYC is linked to diffuse large B-cell lymphoma.